Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S, a global healthcare leader, has announced a share repurchase program where it is set to buy back B shares for up to DKK 2.2 billion from May 7, 2024, to August 5, 2024. This is part of a larger DKK 20 billion share repurchase plan over a 12-month period starting February 6, 2024. As of June 28, 2024, the company has repurchased 10,061,625 B shares at an average price of DKK 873.45, amounting to a transaction value of DKK 8,788,370,170.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
